Latest Breaking News On - Calvin sandberg - Page 1 : comparemela.com
PerkinElmer, Inc.: PerkinElmer to Acquire Oxford Immunotec Global PLC
Transaction expected to be completed in the first half of 2021
PerkinElmer, Inc. (NYSE: PKI) (
Oxford Immunotec or the
Company ) are pleased to announce they have reached an agreement on terms under which PerkinElmer will acquire Oxford Immunotec (the
Acquisition ). It is intended that the Acquisition will be implemented by means of a U.K. High Court of Justice-sanctioned scheme of arrangement under Part 26 of the U.K. Companies Act 2006 between Oxford Immunotec and its shareholders (the
Scheme
Under the terms of the Acquisition, Oxford Immunotec shareholders will be entitled to receive USD 22.00 in cash for each outstanding ordinary share (
New-yorkUnited-statesJapanDistrict-of-columbiaUnited-kingdomChinaBostonMassachusettsNorthern-irelandCraigavonLondonCity-of